|Bid||10.56 x 2900|
|Ask||0.00 x 800|
|Day's Range||10.56 - 11.08|
|52 Week Range||10.35 - 11.50|
|Beta (5Y Monthly)||-0.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 08, 2021 - Jan 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that it has elected to extend the date by which it has to consummate a business combination from November 30, 2020 to May 29, 2021 (the "Extension").
Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or "LOAC"), a publicly-traded special purpose acquisition company (SPAC), announced that in light of the upcoming special shareholder meeting (the "Special Meeting"), if the shareholders approves the proposal to extend the date by which the Company must complete its initial business combination from November 30, 2020 to May 29, 2021 or such earlier date as determined by the board (the "Extension"), for each public share that is not redeemed by the Company's shareholders in connection with the Extension (each, a "Remaining Share"), for each monthly period, or portion thereof during the Extension, it will deposit $0.05 per share into the trust account as additional interest on the proceeds in the trust account Extension (the " Increased Cash Contribution"). This Increased Cash Contribution replaces the previously announced cash contribution of $0.025 per month for each Remaining Share.
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: